Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group-Reference-Cited by-同舟云学术

Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group

Published:2024-01 Issue: Volume:233 Page:153-164
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Frenzel Laurent,Decaux Olivier,Macro Margaret,Belhadj-Merzoug Karim,Manier Salomon,Touzeau Cyrille,Leleu Xavier,Frère Corinne,Lecompte Thomas,Perrot Aurore,Avet-Loiseau Hervé,Moreau Philippe,Chalayer Emilie

Publisher

Elsevier BV

Subject

Hematology

Reference58 articles.

1. Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma;Kristinsson;Blood,2008

2. Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study;Kristinsson;Blood,2010

3. A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma;Hicks;Cancer Treat. Rev.,2008

4. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma;Palumbo;Leukemia,2008

5. Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: analysis of vascular thrombotic events in the GRIFFIN study;Sborov;Br. J. Haematol.,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide;Blood Reviews;2024-07

2. Multiple myeloma;Nature Reviews Disease Primers;2024-06-27

3. Monoclonal whole IgG impairs both fibrin and thrombin formation: hemostasis and surface plasmon resonance studies;Clinical Chemistry and Laboratory Medicine (CCLM);2024-06-25

4. Az elérhető gyógyulás küszöbén: innovációk a myeloma multiplex kezelésében;Orvosi Hetilap;2024-06-09

5. Bleeding risk from anticoagulant thromboprophylaxis in patients with multiple myeloma: a MarketScan analysis;Research and Practice in Thrombosis and Haemostasis;2024-05